• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On September 18, Federal Reserve Chairman Powell, in response to questions about the central banks statutory requirement to achieve "moderate long-term interest rates" at a press conference following the interest rate decision on Wednesday, explained why the three missions given to the Federal Reserve by Congress can be reduced to two major tasks in practice. Central bank officials have long positioned their mission as a dual task, with monetary policy focusing on keeping inflation low and stable and ensuring a continued strong job market, with little emphasis on the third task. Powell told reporters that the third task is real, but in the eyes of central bankers, it is a derivative of the two more well-known goals stipulated by law. He said: "We believe that moderate long-term interest rates are the result of achieving low and stable inflation and maximum employment." For some time, Federal Reserve officials did not believe that the third task required "independent action."1. The three major U.S. stock indices closed mixed, with the Dow Jones Industrial Average up 0.57%, the S&P 500 down 0.1%, and the Nasdaq down 0.33%. American Express and Caterpillar rose over 2%, leading the Dow higher. The Wind US Tech 7 Index fell 0.66%, with Nvidia down over 2% and Amazon down over 1%. Chinese concept stocks generally rose, with Baidu Group up over 11% and ACM Semiconductor up over 9%. The Federal Reserve announced a 25 basis point interest rate cut as expected. The markets positive reaction to the policy shift provided support for U.S. stocks, but the divergent performance of technology stocks curbed overall gains. 2. U.S. Treasury yields rose across the board, with the 2-year Treasury yield up 4.99 basis points to 3.545%, the 3-year Treasury yield up 6.40 basis points to 3.533%, the 5-year Treasury yield up 6.77 basis points to 3.652%, the 10-year Treasury yield up 6.12 basis points to 4.089%, and the 30-year Treasury yield up 3.86 basis points to 4.690%. Federal Reserve Chairman Powell emphasized that inflation remains high and stated that future rate cuts will be data-dependent, prompting the market to reassess tightening risks. 3. International precious metals futures generally closed lower, with COMEX gold futures down 0.82% to $3,694.60 per ounce and COMEX silver futures down 2.15% to $41.99 per ounce. 4. International oil prices fell slightly, with the main US crude oil contract closing down 0.85% at $63.97 per barrel; the main Brent crude oil contract fell 0.82% to $67.91 per barrel. 5. Most base metals prices in London fell, with LME zinc down 1.64% to $2,943 per ton, LME copper down 1.51% to $9,974 per ton, LME tin down 1.41% to $34,390 per ton, LME aluminum down 1.01% to $2,689.50 per ton, LME lead down 0.25% to $2,005 per ton, and LME nickel up 0.11% to $15,445 per ton. Expectations of loose monetary policy pushed the US dollar index to a yearly low, providing support for dollar-denominated base metals from a cost perspective.On September 18, the Hong Kong Monetary Authority lowered the benchmark interest rate by 25 basis points to 4.50%, and the Federal Reserve cut interest rates by 25 basis points overnight.Market news: The U.S. House of Representatives cleared procedural obstacles to voting on a temporary appropriations bill.On September 18th, Venezuelan Defense Minister Lopez Obrador announced the three-day "Sovereign Caribbean 200" military exercises on Orchila Island. The exercises, personally ordered by President Maduro, are intended to respond to US threats. The exercises will mobilize over 2,500 military personnel. The exercises will involve coordinated operations by the navy, army, and air force, involving 12 naval vessels of various classes, 22 military aircraft, and over 20 auxiliary vessels.

Novavax Reduces Its Full-year Revenue Forecast Due to Sluggish Demand

Haiden Holmes

Nov 09, 2022 15:55

52.png


Novavax (NASDAQ:NVAX) decreased its full-year revenue guidance for the second time in three months on Tuesday as a result of a global supply glut in COVID-19 vaccine and declining demand.


The company now expects its annual revenues to fall within the lower half of its earlier forecast range of $2 billion to $2.3 billion.


Novavax reduced its revenue forecast for the year in August, since the business did not expect to sell any additional COVID-19 vaccine in the United States this year.


Filip Dubovsky, the chief medical officer of Novavax, stated on a conference call with investors that the company is "moving forward" with the development of a vaccine against Omicron sub variants BQ.1 and BQ.1.1, which would also be formulated as a bivalent vaccination with another coronavirus strain.


Dubovsky noted that Novavax intends to get the vaccine ready by the second quarter of 2019 in time for an expected surge in cases in the southern hemisphere.


Novavax stated Tuesday morning that its COVID-19 vaccine has been modified for the Omicron BA.


In advanced study, one variant generated a substantial immune response at the fourth dose, meeting the strain swift's main purpose.


The shares of the Maryland-based firm surged by nearly 1 percent in afternoon trading after the company reported third-quarter revenues that were above analyst projections.


Last week, Pfizer Inc. (NYSE:PFE) increased its annual COVID vaccination sales projection. After the government ceases buying doses and sales move to the private sector, the company intends to almost double the price of the vaccine injection in the United States in order to combat declining sales.


Even though more than 640 million COVID-19 doses have been distributed in the United States, just 43,540 Novavax vaccines have been delivered as of November 2, according to the most current government figures.


In October, the U.S. Food and Drug Administration authorized the COVID-19 vaccine as a booster for adults, in addition to its existing clearance as a primary two-shot regimen for those 12 and older.